The synthetic drug fenoldopam mesylate (FM) may have a renoprotective role, and a "renal dose" of 0.1 µg/kg/min intravenous (IV) infusion of FM has been reported as able to increase renal blood flow without affecting systemic blood pressure. But conclusive data are still lacking. We aimed to investigate by color-Doppler ultrasonography the effects of IV administration of FM at this dosage in hypertensive chronic kidney disease (CKD) patients, and verify whether it may induce any systemic hemodynamic alteration.
Rovella, V., Ferrannini, M., Tesauro, M., Marrone, G., Busca, A., Sorge, R., et al. (2019). Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease. JN. JOURNAL OF NEPHROLOGY, 32(1), 75-81 [10.1007/s40620-018-0496-0].
Tipologia: | Articolo su rivista | |
Citazione: | Rovella, V., Ferrannini, M., Tesauro, M., Marrone, G., Busca, A., Sorge, R., et al. (2019). Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease. JN. JOURNAL OF NEPHROLOGY, 32(1), 75-81 [10.1007/s40620-018-0496-0]. | |
Lingua: | English | |
Settore Scientifico Disciplinare: | Settore MED/09 | |
Revisione (peer review): | Esperti anonimi | |
Tipo: | Articolo | |
Rilevanza: | Rilevanza internazionale | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/s40620-018-0496-0 | |
Stato di pubblicazione: | Pubblicato | |
Data di pubblicazione: | 2019 | |
Titolo: | Effects of fenoldopam on renal blood flow in hypertensive chronic kidney disease | |
Autori: | ||
Autori: | Rovella, V; Ferrannini, M; Tesauro, M; Marrone, G; Busca, A; Sorge, R; Manca di Villahermosa, S; Casasco, M; Di Daniele, N; Noce, A | |
Appare nelle tipologie: | 01 - Articolo su rivista |